NYSE:STESteris Stock Price, Forecast & News

$143.68

+4.96 (+3.58 %)

(As of 04/6/2020 10:04 AM ET)

Add

Compare

Today's Range

$142.70

Now: $143.68▼

$145.64

50-Day Range

$107.76

MA: $147.73▼

$168.51

52-Week Range

$105.69

Now: $143.68▼

$168.98

Volume35,713 shs

Average Volume912,071 shs

Market Capitalization$12.19 billion

P/E Ratio31.23

Dividend Yield1.07%

Beta0.86

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.

Beat the Market (BTM) Rank^™

1.5 Analyst's Opinion

Consensus Rating
Steris has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $144.33, Steris has a potential upside of 1.1% from its current price of $142.70.
Amount of Analyst Coverage
Steris has only been the subject of 2 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
Steris has received 274 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Steris has received 380 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Steris has received 58.10% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote “Outperform” if you believe STE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.

5.0 Dividend Strength

Dividend Leadership
Steris is a leading dividend payer. It pays a dividend yield of 1.07%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Steris has been increasing its dividend for 10 years.
Dividend Coverage
The dividend payout ratio of Steris is 30.27 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Steris will have a dividend payout ratio of 23.87 % next year. This indicates that Steris will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Steris insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $516,994.00 in company stock.
Percentage Held by Insiders
Only 2.36% of the stock of Steris is held by insiders.
Percentage Held by Institutions
87.85% of the stock of Steris is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Steris are expected to grow by 10.32% in the coming year, from $5.62 to $6.20 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Steris is 31.02, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 11.39.
Price to Earnings Ratio vs. Sector
The P/E ratio of Steris is 31.02, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 19.67.
Price to Book Value per Share Ratio
Steris has a P/B Ratio of 3.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.05 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Surgical appliances & supplies

Sub-IndustryHealth Care Equipment

SectorMedical

Current SymbolNYSE:STE

Previous Symbol

CUSIP85915210

CIK1624899

Webhttp://www.steris.com/

Phone353-1232-2000

Debt

Debt-to-Equity Ratio0.37

Current Ratio2.34

Quick Ratio1.78

Price-To-Earnings

Trailing P/E Ratio31.23

Forward P/E Ratio25.57

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.78 billion

Price / Sales4.38

Cash Flow$7.88 per share

Price / Cash Flow18.24

Book Value$37.66 per share

Price / Book3.82

Profitability

EPS (Most Recent Fiscal Year)$4.89

Net Income$304.05 million

Net Margins13.21%

Return on Equity16.33%

Return on Assets9.09%

Miscellaneous

Employees12,000

Outstanding Shares84,810,000

Market Cap$12.19 billion

Next Earnings Date5/11/2020 (Estimated)

OptionableOptionable

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock been impacted by COVID-19 (Coronavirus)?

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, STE stock has decreased by 1.8% and is now trading at $142.70. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Steris?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Steris.

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Steris.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) issued its earnings results on Monday, February, 10th. The medical equipment provider reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.03. The medical equipment provider had revenue of $774.30 million for the quarter, compared to the consensus estimate of $748.45 million. Steris had a return on equity of 16.33% and a net margin of 13.21%. The business's revenue for the quarter was up 11.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.26 EPS. View Steris' earnings history.

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Monday, February 10th. Stockholders of record on Tuesday, February 25th will be given a dividend of $0.37 per share on Thursday, March 26th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date of this dividend is Monday, February 24th. View Steris' dividend history.

What guidance has Steris issued on next quarter's earnings?

Steris issued an update on its FY 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided EPS guidance of 5.65-5.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.57.

What price target have analysts set for STE?

4 brokers have issued 1 year price objectives for Steris' stock. Their forecasts range from $138.00 to $150.00. On average, they anticipate Steris' stock price to reach $144.33 in the next twelve months. This suggests a possible upside of 1.1% from the stock's current price. View analysts' price targets for Steris.

Has Steris been receiving favorable news coverage?

News stories about STE stock have been trending very negative on Monday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Steris earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutSteris.

Are investors shorting Steris?

Steris saw a decrease in short interest during the month of March. As of March 13th, there was short interest totaling 1,275,100 shares, a decrease of 18.8% from the February 27th total of 1,570,000 shares. Based on an average daily volume of 881,000 shares, the short-interest ratio is currently 1.4 days. Currently, 1.5% of the company's stock are short sold. View Steris' Current Options Chain.

Who are some of Steris' key competitors?

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Stryker (SYK), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Insulet (PODD), Masimo (MASI) and Varian Medical Systems (VAR).

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Mastercard (MA), AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Stryker (SYK), Zimmer Biomet (ZBH), Zoetis (ZTS), Abbott Laboratories (ABT) and Mcdonald's (MCD).

Who are Steris' key executives?

Steris' management team includes the following people:

Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are Steris' major shareholders?

Steris' stock is owned by many different retail and institutional investors. Top institutional shareholders include Deane Retirement Strategies Inc. (0.01%), Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%) and Fulton Bank N.A. (0.00%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View institutional ownership trends for Steris.

Which institutional investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Fulton Bank N.A.. Company insiders that have sold Steris company stock in the last year include Cary L Majors, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, and Walter M Rosebrough Jr. View insider buying and selling activity for Steris.

Which institutional investors are buying Steris stock?

STE stock was purchased by a variety of institutional investors in the last quarter, including Deane Retirement Strategies Inc., and Nelson Van Denburg & Campbell Wealth Management Group LLC. View insider buying and selling activity for Steris.

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $142.70.

How big of a company is Steris?

Steris has a market capitalization of $12.10 billion and generates $2.78 billion in revenue each year. The medical equipment provider earns $304.05 million in net income (profit) each year or $4.89 on an earnings per share basis. Steris employs 12,000 workers across the globe. View additional information about Steris.

What is Steris' official website?

The official website for Steris is http://www.steris.com/.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: Growth and Income Funds

NYSE:STESteris Stock Price, Forecast & News

Adding

Adding

Adding Steris PLC

Beat the Market (BTM) Rank™

1.5 Analyst's Opinion

Consensus Rating

Price Target Upside/Downside

Amount of Analyst Coverage